Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  estramustine phosphate sodium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 72 for your search:
Start Over
Phase II/III Randomized Study of EM/VBL vs EM for Metastatic Hormone-Refractory Prostate Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30944
Phase III Randomized Study of VBL vs VBL/EM for Metastatic Hormone-Refractory Prostate Cancer (Summary Last Modified 06/96)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HOG-GU93-1, NCI-V94-0424
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
Phase III Study of Adjuvant Estramustine and Etoposide vs Observation Following Radical Prostatectomy for Stage II, III, or IV Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18-70
Sponsor: NCI
Protocol IDs: CWRU-1894, NCI-G97-1360
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067211, S9916, U10CA032102, SWOG-S9916, CLB-99808, NCCTG-S9916, NCT00004001
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-9902, CDR0000067250, RTOG-DEV-1020, NCT00004054
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: ID00-156, U10CA045809, P30CA016672, MDA-ID-00156, NCI-3410, CDR0000068897, NCI-2009-00009, 3410, NCT00024167
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654
Phase III Radiotherapy Followed by Estracyt or CTX for Stage B/C/D Prostatic Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-1000
Phase III MTX vs CTX/ADR vs CTX/5-FU/CACP with Estracyt/CACP as Crossover Therapy for Failures for Hormone-Refractory Metastatic Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-1500
Phase III Estracyt vs CTX After Prostatectomy for Stage B2/C/D1 Prostatic Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NPCTG-900
Phase III Randomized Study of VBL vs VBL/EM in Patients with Metastatic Hormone-Refractory Prostate Cancer (Summary Last Modified 01/94)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-91059, NCI-T92-0007D, T92-0007
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 80
Sponsor: Other
Protocol IDs: CDR0000270970, FRE-FNCLCC-GETUG-12/0203, EU-20238, NCT00055731
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069088, E1899, SWOG-E1899, CALGB-E1899, ECOG-E1899, NCT00027859
Phase I/II Study of Vinorelbine/Estramustine for Hormone-Refractory Prostate Cancer (Summary Last Modified 07/97)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: UCLA-9411413, NCI-V95-0619
Phase I/II Study of Estramustine/Vinblastine plus 3-Dimensional Conformal Radiotherapy for Poor-Prognosis Nonmetastatic Prostate Cancer (Summary Last Modified 01/99)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: MSKCC-95082, NCI-T96-0049H, T96-0049
Phase I/II Study of Weekly Paclitaxel in Combination with Estramustine and Carboplatin in Patients with Advanced Prostate Cancer (Summary Last Modified 01/2000)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-97025, NCI-G97-1269
Combination Chemotherapy in Treating Patients With Advanced Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067324, P30CA016087, NYU-9712, NCI-G99-1596, NCT00004105
Phase I/II Randomized Study of Ixabepilone With or Without Estramustine in Patients With Progressive Androgen-Independent Adenocarcinoma of the Prostate
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01064, MSKCC-01064A, NCI-3634, NCT00025194, 3634
Phase I/II Study of Intravenous Estramustine and Paclitaxel in Patients With Hormone Refractory Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-98268
Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000355825, MDA-ID-00087, ID00-087, NCT00082693
Start Over